Merck & Co., Inc.
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 17.3B 15.8B 15.5B 15.6B
Cost of revenue 3.9B 3.6B 3.4B 3.8B
Gross profit 13.4B 12.2B 12.1B 11.8B
Operating expense
Research & development 4.2B 4.0B 3.6B 4.6B
Selling general and admin 2.6B 2.6B 2.6B 2.9B
Other operating expenses
Operating income 6.6B 5.6B 5.9B 4.3B
Non operating interest income
Income 96M 69M 109M 146M
Expense 327M 305M 313M 328M
Other income expense 422M -317M 170M 4M
Pretax income 6.7B 5.0B 5.9B 4.2B
Tax provision 958M 571M 818M 426M
Net income 5.8B 4.4B 5.1B 3.7B
Basic EPS 1.8 2.0 1.5
Diluted EPS 1.8 2.0 1.5
Basic average shares 2.5B 2.5B 2.5B
Diluted average shares 2.5B 2.5B 2.5B
EBITDA 8.0B 7.0B 7.4B 6.0B
Net income from continuing op. 5.8B 4.4B 5.1B 3.7B
Minority interests -2M -1M -6M -1M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 9 hours 1 minute

00:28
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).